{"id":"application-of-the-topic-gel","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL3544774","moleculeType":"Small molecule"},"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"Without specific active pharmaceutical ingredient information, the exact mechanism cannot be determined. Topic gels are typically formulations that deliver therapeutic agents directly to the site of application, allowing for localized treatment while minimizing systemic exposure. The specific mechanism would depend on the active ingredient(s) contained within the gel matrix.","oneSentence":"A topical gel formulation designed for local application to affected skin or mucosal areas.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:02:08.123Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07240519","phase":"NA","title":"To Compare Inflammatory Biomarkers Before and After Treatment With Clobetasol or Fractional CO2 Laser, in Women With Histologically Confirmed Vulvar Lichen Sclerosus, Without Prior Corticosteroid Treatment.","status":"RECRUITING","sponsor":"Universidade Federal do Rio de Janeiro","startDate":"2022-06-22","conditions":"Vulvar Lichen Sclerosus","enrollment":40},{"nctId":"NCT06116045","phase":"PHASE2","title":"Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women with Sexual Arousal Disorder","status":"RECRUITING","sponsor":"Biozeus Biopharmaceutical S.A.","startDate":"2024-10-01","conditions":"Female Sexual Arousal Disorder, Female Sexual Dysfunction","enrollment":30},{"nctId":"NCT06202495","phase":"NA","title":"Dentine Hypersensitivity Treated With Laser and Fluoride.","status":"UNKNOWN","sponsor":"University of Pavia","startDate":"2024-01-15","conditions":"Sensitive Dentin","enrollment":43},{"nctId":"NCT05710874","phase":"NA","title":"A Prospective, Randomized, Clinical Study on the Effects of CPP-ACP-paste, Fluoride and a Combination on the Evolution of White Spot Lesions in Orthodontic Patients After Debonding.","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2016-09-23","conditions":"White Spot Lesion, Orthodontic Appliance Complication","enrollment":107},{"nctId":"NCT02762084","phase":"PHASE2","title":"Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas in Gorlin Syndrome Patients","status":"COMPLETED","sponsor":"PellePharm, Inc.","startDate":"2016-06-06","conditions":"Basal Cell Nevus Syndrome","enrollment":17},{"nctId":"NCT02300194","phase":"PHASE4","title":"Randomized, Double-blind, Placebo, Controlled Cross Over Design Topical Morphine for Analgesia in Pediatric Procedures","status":"WITHDRAWN","sponsor":"Hospital General de Niños Pedro de Elizalde","startDate":"2014-12","conditions":"Pain","enrollment":""},{"nctId":"NCT02828111","phase":"PHASE2","title":"Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas","status":"COMPLETED","sponsor":"PellePharm, Inc.","startDate":"2016-11-11","conditions":"Basal Cell Carcinomas","enrollment":36},{"nctId":"NCT03281187","phase":"PHASE3","title":"Efficacy and Safety of Testosterone Nasal Gel for Treating Hypogonadism in Men.","status":"UNKNOWN","sponsor":"FBM Industria Brasileira Ltda","startDate":"2018-07-16","conditions":"Hypogonadism","enrollment":228},{"nctId":"NCT02761525","phase":"NA","title":"Topical Application of Silver Nanoparticles and Oral Pathogens in Ill Patients","status":"COMPLETED","sponsor":"Universidad Autonoma de San Luis Potosí","startDate":"2014-10","conditions":"Critical Illness","enrollment":50},{"nctId":"NCT00838812","phase":"PHASE3","title":"Safety and Efficacy Study of Association Between Tretinoin and Clindamycin on the Treatment of Acne Mild and Moderate","status":"COMPLETED","sponsor":"Igefarma Laboratorios S.A.","startDate":"2009-03","conditions":"Acne Vulgaris","enrollment":154}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":581,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"application of the topic gel","genericName":"application of the topic gel","companyName":"Igefarma Laboratorios S.A.","companyId":"igefarma-laboratorios-s-a","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}